Annual Accounts Payable
$427.00 K
-$469.00 K-52.34%
December 31, 2023
Summary
- As of February 7, 2025, CANF annual accounts payable is $427.00 thousand, with the most recent change of -$469.00 thousand (-52.34%) on December 31, 2023.
- During the last 3 years, CANF annual accounts payable has fallen by -$134.00 thousand (-23.89%).
- CANF annual accounts payable is now -80.19% below its all-time high of $2.16 million, reached on December 31, 2019.
Performance
CANF Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$885.00 K
+$458.00 K+107.26%
June 30, 2024
Summary
- As of February 7, 2025, CANF quarterly accounts payable is $885.00 thousand, with the most recent change of +$458.00 thousand (+107.26%) on June 30, 2024.
- Over the past year, CANF quarterly accounts payable has increased by +$75.00 thousand (+9.26%).
- CANF quarterly accounts payable is now -58.95% below its all-time high of $2.16 million, reached on December 1, 2019.
Performance
CANF Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CANF Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -52.3% | +9.3% |
| 3 y3 years | -23.9% | -11.9% |
| 5 y5 years | -60.1% | -41.4% |
CANF Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.2% | at low | -39.9% | +107.3% |
| 5 y | 5-year | -80.2% | at low | -59.0% | +205.2% |
| alltime | all time | -80.2% | +62.4% | -59.0% | +236.5% |
Can-Fite BioPharma Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $885.00 K(+107.3%) |
| Dec 2023 | $427.00 K(-52.3%) | $427.00 K(-34.0%) |
| Sep 2023 | - | $647.00 K(-20.1%) |
| Jun 2023 | - | $810.00 K(-15.9%) |
| Mar 2023 | - | $963.00 K(+7.5%) |
| Dec 2022 | $896.00 K(-6.1%) | $896.00 K(-39.1%) |
| Sep 2022 | - | $1.47 M(+78.6%) |
| Jun 2022 | - | $824.00 K(-26.7%) |
| Mar 2022 | - | $1.12 M(+17.8%) |
| Dec 2021 | $954.00 K(+70.1%) | $954.00 K(+18.4%) |
| Sep 2021 | - | $806.00 K(-19.8%) |
| Jun 2021 | - | $1.00 M(+246.6%) |
| Mar 2021 | - | $290.00 K(-48.3%) |
| Dec 2020 | $561.00 K(-74.0%) | $561.00 K(-28.4%) |
| Sep 2020 | - | $784.00 K(+79.4%) |
| Jun 2020 | - | $437.00 K(-79.7%) |
| Dec 2019 | $2.16 M(+101.3%) | - |
| Dec 2019 | - | $2.16 M(+58.1%) |
| Sep 2019 | - | $1.36 M(-9.7%) |
| Jun 2019 | - | $1.51 M(+16.5%) |
| Mar 2019 | - | $1.30 M(+21.0%) |
| Dec 2018 | $1.07 M(+150.8%) | - |
| Dec 2018 | - | $1.07 M(-28.8%) |
| Sep 2018 | - | $1.50 M(+10.2%) |
| Jun 2018 | - | $1.36 M(-24.9%) |
| Mar 2018 | - | $1.82 M(+325.5%) |
| Dec 2017 | $427.00 K | - |
| Dec 2017 | - | $427.00 K(-60.4%) |
| Sep 2017 | - | $1.08 M(-16.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $1.29 M(-20.7%) |
| Mar 2017 | - | $1.63 M(+30.1%) |
| Dec 2016 | $1.25 M(+170.4%) | - |
| Dec 2016 | - | $1.25 M(-9.9%) |
| Sep 2016 | - | $1.39 M(+0.9%) |
| Jun 2016 | - | $1.37 M(-25.4%) |
| Mar 2016 | - | $1.84 M(+298.5%) |
| Dec 2015 | $461.90 K(+75.6%) | - |
| Dec 2015 | - | $461.90 K(-60.4%) |
| Sep 2015 | - | $1.17 M(+4.5%) |
| Jun 2015 | - | $1.12 M(-5.2%) |
| Mar 2015 | - | $1.18 M(+347.4%) |
| Dec 2014 | $263.00 K(-55.5%) | - |
| Dec 2014 | - | $263.00 K(-82.0%) |
| Sep 2014 | - | $1.46 M(+13.5%) |
| Jun 2014 | - | $1.29 M(-17.3%) |
| Mar 2014 | - | $1.56 M(+164.0%) |
| Dec 2013 | $590.40 K(-70.2%) | $590.40 K(-53.7%) |
| Sep 2013 | - | $1.27 M(-5.1%) |
| Jun 2013 | - | $1.34 M(+135.9%) |
| Mar 2013 | - | $569.60 K(-71.3%) |
| Dec 2012 | $1.98 M(+291.0%) | - |
| Dec 2012 | - | $1.98 M(+312.5%) |
| Sep 2012 | - | $480.60 K(-50.0%) |
| Jun 2012 | - | $960.40 K(-34.7%) |
| Mar 2012 | - | $1.47 M(+189.9%) |
| Dec 2011 | $507.10 K | - |
| Dec 2011 | - | $507.10 K(-48.0%) |
| Sep 2011 | - | $975.00 K |
FAQ
- What is Can-Fite BioPharma annual accounts payable?
- What is the all time high annual accounts payable for Can-Fite BioPharma?
- What is Can-Fite BioPharma annual accounts payable year-on-year change?
- What is Can-Fite BioPharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for Can-Fite BioPharma?
- What is Can-Fite BioPharma quarterly accounts payable year-on-year change?
What is Can-Fite BioPharma annual accounts payable?
The current annual accounts payable of CANF is $427.00 K
What is the all time high annual accounts payable for Can-Fite BioPharma?
Can-Fite BioPharma all-time high annual accounts payable is $2.16 M
What is Can-Fite BioPharma annual accounts payable year-on-year change?
Over the past year, CANF annual accounts payable has changed by -$469.00 K (-52.34%)
What is Can-Fite BioPharma quarterly accounts payable?
The current quarterly accounts payable of CANF is $885.00 K
What is the all time high quarterly accounts payable for Can-Fite BioPharma?
Can-Fite BioPharma all-time high quarterly accounts payable is $2.16 M
What is Can-Fite BioPharma quarterly accounts payable year-on-year change?
Over the past year, CANF quarterly accounts payable has changed by +$75.00 K (+9.26%)